Sunshine Biopharma Inc. (SBFM) Gross profit 2017–2025
Sunshine Biopharma Inc. (SBFM) annual gross profit history from SEC filings — each fiscal year as reported.
$12.3MFY2025 · since FY2017: $0 → $12.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.3M | +14.9% |
| FY2024 | $10.7M | +27.9% |
| FY2023 | $8.3M | +391.5% |
| FY2022 | $1.7M | +1434.0% |
| FY2021 | $110,596 | +142.7% |
| FY2020 | $45,563 | +352.4% |
| FY2019 | $10,071 | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →